metformin and gw 7647

metformin has been researched along with gw 7647 in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Davis, MI; Khan, J; Li, SQ; Patel, PR; Shen, M; Sun, H; Thomas, CJ1
Fujii, H; Ishiba, H; Ito, Y; Itoh, Y; Kamon, J; Kataoka, S; Liu, Y; Moriguchi, M; Okanoue, T; Okishio, S; Okuda, K; Seko, Y; Takahashi, A; Takahashi, D; Tochiki, N; Umemura, A; Yamaguchi, K; Yano, K; Yasui, K1

Other Studies

2 other study(ies) available for metformin and gw 7647

ArticleYear
Identification of potent Yes1 kinase inhibitors using a library screening approach.
    Bioorganic & medicinal chemistry letters, 2013, Aug-01, Volume: 23, Issue:15

    Topics: Binding Sites; Cell Line; Cell Survival; Drug Design; Humans; Hydrogen Bonding; Molecular Docking Simulation; Protein Kinase Inhibitors; Protein Structure, Tertiary; Proto-Oncogene Proteins c-yes; Small Molecule Libraries; Structure-Activity Relationship

2013
PPARĪ± agonist and metformin co-treatment ameliorates NASH in mice induced by a choline-deficient, amino acid-defined diet with 45% fat.
    Scientific reports, 2020, 11-11, Volume: 10, Issue:1

    Topics: Alanine Transaminase; Amino Acids; Animals; Anti-Inflammatory Agents, Non-Steroidal; Antioxidants; Aspartate Aminotransferases; Butyrates; Choline Deficiency; Diet; Disease Models, Animal; Drug Therapy, Combination; Endoplasmic Reticulum Stress; Fibroblast Growth Factors; Male; Metformin; Mice, Inbred C57BL; Non-alcoholic Fatty Liver Disease; Phenylurea Compounds; PPAR alpha

2020